CN101918536B - 用于人类和/或动物的营养的组合物、它们的应用和酵母菌 - Google Patents

用于人类和/或动物的营养的组合物、它们的应用和酵母菌 Download PDF

Info

Publication number
CN101918536B
CN101918536B CN2008801228126A CN200880122812A CN101918536B CN 101918536 B CN101918536 B CN 101918536B CN 2008801228126 A CN2008801228126 A CN 2008801228126A CN 200880122812 A CN200880122812 A CN 200880122812A CN 101918536 B CN101918536 B CN 101918536B
Authority
CN
China
Prior art keywords
yeast
scpro1
strain
scb1
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2008801228126A
Other languages
English (en)
Chinese (zh)
Other versions
CN101918536A (zh
Inventor
让-吕克·西蒙
乔治·皮涅德
帕斯卡尔·范德克尔克奥韦
达尼埃尔·普兰
皮埃尔·德勒莫
阿莱特·达尔弗耶-米肖
阿德琳·西维尼恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lesaffre et Cie SA
Universite Lille 2 Droit et Sante
Universite Clermont Auvergne
Original Assignee
Lesaffre et Cie SA
Universite Lille 2 Droit et Sante
Universite Clermont Auvergne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0801342A external-priority patent/FR2928652B1/fr
Application filed by Lesaffre et Cie SA, Universite Lille 2 Droit et Sante, Universite Clermont Auvergne filed Critical Lesaffre et Cie SA
Publication of CN101918536A publication Critical patent/CN101918536A/zh
Application granted granted Critical
Publication of CN101918536B publication Critical patent/CN101918536B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/18—Baker's yeast; Brewer's yeast
    • C12N1/185—Saccharomyces isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/85—Saccharomyces
    • C12R2001/865—Saccharomyces cerevisiae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
CN2008801228126A 2007-12-26 2008-12-12 用于人类和/或动物的营养的组合物、它们的应用和酵母菌 Active CN101918536B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0760377 2007-12-26
FR0760377 2007-12-26
FR0801342A FR2928652B1 (fr) 2008-03-12 2008-03-12 Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
FR0801342 2008-03-12
PCT/FR2008/001729 WO2009103884A2 (fr) 2007-12-26 2008-12-12 Composition pour l'alimentation humaine et/ou animale, ses utilisations, levures

Publications (2)

Publication Number Publication Date
CN101918536A CN101918536A (zh) 2010-12-15
CN101918536B true CN101918536B (zh) 2013-07-03

Family

ID=40985983

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008801228126A Active CN101918536B (zh) 2007-12-26 2008-12-12 用于人类和/或动物的营养的组合物、它们的应用和酵母菌

Country Status (24)

Country Link
US (1) US8476058B2 (cg-RX-API-DMAC7.html)
EP (1) EP2227539B1 (cg-RX-API-DMAC7.html)
JP (1) JP5497661B2 (cg-RX-API-DMAC7.html)
KR (1) KR101654537B1 (cg-RX-API-DMAC7.html)
CN (1) CN101918536B (cg-RX-API-DMAC7.html)
AU (1) AU2008351156B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0820068B8 (cg-RX-API-DMAC7.html)
CA (1) CA2709850C (cg-RX-API-DMAC7.html)
DK (1) DK2227539T3 (cg-RX-API-DMAC7.html)
ES (1) ES2649914T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20171632T1 (cg-RX-API-DMAC7.html)
HU (1) HUE034628T2 (cg-RX-API-DMAC7.html)
IL (1) IL206110A (cg-RX-API-DMAC7.html)
LT (1) LT2227539T (cg-RX-API-DMAC7.html)
MX (1) MX2010007011A (cg-RX-API-DMAC7.html)
MY (1) MY159379A (cg-RX-API-DMAC7.html)
NO (1) NO2227539T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ586417A (cg-RX-API-DMAC7.html)
PL (1) PL2227539T3 (cg-RX-API-DMAC7.html)
RU (1) RU2490324C2 (cg-RX-API-DMAC7.html)
SI (1) SI2227539T1 (cg-RX-API-DMAC7.html)
TN (1) TN2010000239A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009103884A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201003978B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876798A1 (fr) * 2004-10-14 2006-04-21 Univ Clermont Auvergne Diagnostic et traitement de la maladie de crohn
KR101654537B1 (ko) 2007-12-26 2016-09-06 르샤프르 에 꽁빠니 인간 및/또는 동물 영양을 위한 조성물, 이의 용도 및 효모균
FR2949043B1 (fr) * 2009-08-17 2013-05-17 Lesaffre & Cie Pate boulangere fermentee tolerante a l'appret
KR101933232B1 (ko) * 2011-03-04 2019-03-15 라이온 가부시키가이샤 성장 호르몬 분비 촉진제
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
FR2993179B1 (fr) * 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
WO2015061798A2 (en) * 2013-10-25 2015-04-30 R.F. Technology Consultants, Inc. Compositions and methods comprising yeast organisms and lipid extracts thereof
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
KR101837160B1 (ko) 2016-07-20 2018-03-09 서울대학교산학협력단 신균주 bt-sjp kctc12726bp 및 이의 용도
WO2018052082A1 (ja) * 2016-09-14 2018-03-22 株式会社Ｔｅｓホールディングス Ｌｉｎ２８ａ活性化剤及びその使用
US11523625B2 (en) 2017-08-07 2022-12-13 Techmix, Llc Feed supplement bolus with active yeast
CN109536370A (zh) * 2018-12-10 2019-03-29 浙江华康药业股份有限公司 一种体外发酵糖醇益生功能评价装置及方法
FR3089788B1 (fr) * 2018-12-17 2020-12-18 Lesaffre & Cie Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées
FR3090318B1 (fr) 2018-12-19 2024-06-14 Lesaffre & Cie Souche Saccharomyces cerevisiae var boulardii en santé orale
PL3685681T3 (pl) 2019-01-23 2024-10-21 Lesaffre Et Compagnie Produkt drożdżowy i zawierająca go kompozycja do zastosowania jako środek prebiotyczny
FR3096891B1 (fr) 2019-06-04 2022-05-13 Lesaffre & Cie Composition pour la prevention de la cystite simple et/ou recidivante
CN112273657A (zh) * 2019-07-22 2021-01-29 安琪酵母股份有限公司 用于预防或改善过敏性疾病的益生菌组合物、制法和应用
KR102275115B1 (ko) * 2019-10-16 2021-07-07 한국식품연구원 프로바이오틱 활성을 갖는 사카로마이세스 세레비지애 보울라디­０３ 신균주 및 이의 용도
FR3120789B1 (fr) 2021-03-16 2024-01-19 Lesaffre & Cie Inhibiteurs glycosidiques de levure
CA3223134A1 (en) 2021-06-30 2023-01-05 Carlos DE LECEA Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder
CN118354680A (zh) * 2021-06-30 2024-07-16 英联马利(英国)有限公司 用于治疗胃肠障碍的生理学上可接受的酵母菌组合物
FR3134581B1 (fr) * 2022-04-15 2026-02-27 Lesaffre & Cie Levure Saccharomyces cerevisiae et son utilisation pour améliorer la santé intestinale des animaux de compagnie.
WO2025115611A1 (ja) * 2023-11-30 2025-06-05 株式会社日清製粉グループ本社 免疫調節剤
EP4732843A1 (en) 2024-10-22 2026-04-29 Lesaffre et Compagnie Live saccharomyces cerevisiae strains for the treatment of bone-loss disorders

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481682A1 (en) * 1998-12-09 2004-12-01 N.V. Nutricia Preparation that contains oligosaccharides and probiotics
EP1693064A1 (en) * 2004-12-23 2006-08-23 Biocodex Treating weight loss in patients suffering from inflammatory bowel diseases with S. boulardii

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2233320C2 (ru) * 2001-02-13 2004-07-27 Гриневич Владимир Борисович Способ получения биологически активного препарата, биологически активная добавка (бад) к пище пребиотического действия, приводящая к коррекции (нивелированию) метаболического синдрома и лекарственный препарат для регуляции микробиоценоза желудочно-кишечного тракта
ATE554782T1 (de) 2004-08-23 2012-05-15 Bharat Biotech Int Ltd Synergistische formulierung auf eukaryotischer basis gegen gastrointestinale erkrankungen
US7498367B2 (en) * 2005-02-21 2009-03-03 Kerr Corporation Acid-tolerant dental composition
FR2928652B1 (fr) 2008-03-12 2013-11-15 Lesaffre & Cie Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
KR101654537B1 (ko) 2007-12-26 2016-09-06 르샤프르 에 꽁빠니 인간 및/또는 동물 영양을 위한 조성물, 이의 용도 및 효모균

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481682A1 (en) * 1998-12-09 2004-12-01 N.V. Nutricia Preparation that contains oligosaccharides and probiotics
EP1693064A1 (en) * 2004-12-23 2006-08-23 Biocodex Treating weight loss in patients suffering from inflammatory bowel diseases with S. boulardii

Also Published As

Publication number Publication date
LT2227539T (lt) 2017-11-27
US20100303778A1 (en) 2010-12-02
EP2227539B1 (fr) 2017-08-09
MY159379A (en) 2016-12-30
DK2227539T3 (da) 2017-11-13
US8476058B2 (en) 2013-07-02
RU2010131018A (ru) 2012-02-10
AU2008351156B2 (en) 2013-10-17
SI2227539T1 (en) 2018-03-30
WO2009103884A3 (fr) 2009-12-17
NO2227539T3 (cg-RX-API-DMAC7.html) 2018-01-06
ZA201003978B (en) 2012-02-29
AU2008351156A1 (en) 2009-08-27
IL206110A0 (en) 2010-11-30
BRPI0820068B1 (pt) 2020-03-17
WO2009103884A2 (fr) 2009-08-27
KR101654537B1 (ko) 2016-09-06
CA2709850C (fr) 2018-03-20
JP5497661B2 (ja) 2014-05-21
EP2227539A2 (fr) 2010-09-15
IL206110A (en) 2013-07-31
CA2709850A1 (fr) 2009-08-27
TN2010000239A1 (fr) 2011-11-11
JP2011509651A (ja) 2011-03-31
NZ586417A (en) 2012-07-27
HUE034628T2 (hu) 2018-02-28
RU2490324C2 (ru) 2013-08-20
HRP20171632T1 (hr) 2017-12-15
KR20110066118A (ko) 2011-06-16
PL2227539T3 (pl) 2018-01-31
BRPI0820068A2 (pt) 2015-09-01
BRPI0820068B8 (pt) 2021-07-27
MX2010007011A (es) 2010-10-13
CN101918536A (zh) 2010-12-15
ES2649914T3 (es) 2018-01-16

Similar Documents

Publication Publication Date Title
CN101918536B (zh) 用于人类和/或动物的营养的组合物、它们的应用和酵母菌
RU2551315C2 (ru) Выделение, идентификация и характеристика штаммов с пробиотической активностью, выделенных из фекалий детей, вскармливаемых исключительно материнским молоком
JP2023015099A (ja) 制御性ｔ細胞の増殖または集積を誘導するヒト由来細菌
CN107075455B (zh) 具有抗炎症及代谢疾病改善功效的植物乳杆菌hac01菌株及其用途
US9737577B2 (en) Lactic acid bacterium-containing preparation
KR20140147656A (ko) 비피도박테리움 cect 7765 및 과체중, 비만 및 관련 병리의 예방 및/또는 치료에서의 그의 이용
Tarrah et al. Lactobacillus paracasei DTA81, a cholesterol‐lowering strain having immunomodulatory activity, reveals gut microbiota regulation capability in BALB/c mice receiving high‐fat diet
JP2009142266A (ja) 新規乳酸菌
US20210138004A1 (en) Therapeutic uses of lactobacillus plantarum
WO2009068474A1 (en) Strains of lactobacillus plantarum as probiotics with immunomodulatory specific effect
WO2024211569A1 (en) Compositions and methods for treating or preventing clostridium difficile infection, neutropenia, cardiovascular disease, asthma, and/or cancer
TW202113065A (zh) 腸膜明串珠菌tci007或其代謝產物用於改善過敏狀況的用途
KR20240118626A (ko) 락티플란티바실러스 플란타럼 y7 균주를 포함하는 장 기능 개선용 조성물
CN116333915A (zh) 乳酸菌
FR2928652A1 (fr) Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
TW201609120A (zh) 含乳酸菌之腸道屏障功能促進劑
CN114107083B (zh) 新颖乳酸菌及其用于治疗或预防肝脏损伤相关疾病的用途
길범주 Studies on alleviating intestinal inflammation using probiotic potential of Saccharomyces cerevisiae GILA 118 and its cell wall component
Schropp Do fermented foods modify the human gut microbiota in healthy individuals and improve systemic health? Results from a crossover intervention study with fresh and pasteurized Sauerkraut and in vitro growth experiments with single bacterial species and prebiotics
JP2006257040A (ja) アレルゲン特異的ＩｇＥ抗体産生抑制剤、及びアレルゲン特異的ＩｇＥ抗体産生抑制のために用いられる飲食品
HK1240499B (zh) 胰岛素抵抗改善剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant